Osteoporosis Awareness Among Nursing Students

December 30, 2024 updated by: Esra Cavusoglu, Mersin University

Effect of Scenario-based Teaching on Osteoporosis Awareness in Nursing Students: a Randomized Controlled Trial

The aim of this clinical study is to determine the effect of scenario-based training of nursing students on awareness of osteoporosis.

To this end, the most important questions to be answered in the study are

  • What is the level of osteoporosis awareness among nursing students at the start of the study?
  • Does scenario-based education have an impact on osteoporosis awareness?

Participants:

All student nurses participating in the study will first receive theoretical training on osteoporosis. At the end of the training, a scenario example prepared by the researchers on the topic of osteoporosis is worked on with the students in the experimental group. No additional intervention is carried out with the control group.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

In this study, 78 nursing students randomly assigned to the experimental and control groups are first interviewed using the personal information questionnaire and the Osteoporosis Awareness Scale. This is followed by a four-hour theoretical lesson prepared by the researchers in accordance with current literature and textbooks on osteoporosis as part of the Joint and Connective Tissue Diseases and Nursing course. At the end of the theoretical lessons, a scenario example prepared by the researchers, again using current literature and case presentations, will be worked on with the students in the experimental group. No other application is made for the control group. The Personal Information Questionnaire and the Osteoporosis Awareness Scale will be re-administered to both groups four weeks after the end of the theoretical lesson.

Study Type

Interventional

Enrollment (Estimated)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years of age and above,
  • Mersin University Faculty of Nursing 2nd year students,
  • Have not received any other training on osteoporosis before,
  • Willing to participate in the research,
  • Have cognitive competence to fill out the data collection form,
  • Those who sign the Informed Voluntary Consent Form will be included.

Exclusion Criteria:

  • Those under the age of 18,
  • Not a 2nd year student at Mersin University Faculty of Nursing,
  • Have previously received different training on osteoporosis,
  • Do not want to participate in the research,
  • Do not have the cognitive ability to fill out the data collection form,
  • Those who do not sign the Informed Consent Form will not be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group: Scenario group
Theoretical lesson on osteoporosis and a scenario example on osteoporosis will be covered with the experimental group.
The experimental group will first be given a theoretical lesson prepared in line with the current literature on osteoporosis. At the end of the lesson, a prepared scenario example on osteoporosis will be covered.
Other: Other: Control group
The control group will be given a theoretical lesson on osteoporosis. No additional intervention will be made.
The control group will only be given a theoretical lesson prepared in line with the current literature on osteoporosis. No other intervention will be made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Osteoporosis awareness level will be assessed using the Osteoporosis Awareness Scale.
Time Frame: Change from before implementation and 4th week of practice
The Osteoporosis Awareness Scale consists of 31 items and 5 subscales. Responses to scale items are rated on a 4-point Likert-type scale ranging from 1 to 4 (4 = I know very well, 3 = I know, 2 = I know a little, 1 = I don't know at all). The lowest and highest possible scores from the scale are 31 and 124, respectively. The higher the average score obtained from the overall scale, the higher the osteoporosis awareness.
Change from before implementation and 4th week of practice

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Esra Çavuşoğlu, Doctorate, Mersin University
  • Principal Investigator: Meral Gün, Doctorate, Mersin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2025

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 30, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Interventional

Clinical Trials on Experimental

Subscribe